Global Sample Preparation System for IVD Market 2026 – 2035

The IVD market of Sample Preparation Systems in the world is predicted to be USD 7.15 billion in 2025 and is anticipated to grow to approximately USD 7.71 billion in 2026, and even further rise to about USD 15.81 billion in 2035 at a CAGR of 8.2% between the years of 2026 and 2035.

The factors influencing the market growth include the growing need to have proper and effective diagnostic procedures, the continued rise in the prevalence of infectious and chronic diseases, and the increased use of molecular diagnostics. Also, the growth of the market is being supported by the development of automation in the laboratory and the necessity to process samples in high quantities and error-free.

Market Highlight

• The Asian Pacific dominated the global Sample Preparation System IVD market in 2025 with an estimated market share of 40% of the total market based on the growing diagnostic infrastructure and increase in the volume of testing.

• North America is expected to experience consistent growth at a CAGR of 8.3% between the years 2026 and 2035 due to the higher use of automated laboratory solutions and advanced molecular diagnostics.

• By product type, automated sample preparation systems had the highest portion of approximately 42.2% in 2025 due to their efficiency and accuracy as well as lessening manual intervention.

• Reagents & consumables are anticipated to record the highest growth at 8.4% CAGR during the forecast period owing to their recurrent use as part of diagnostic processes.

• In applications, molecular diagnostics will control the market with approximately 39% of the market share in 2025, whereas infectious disease testing is expected to have the largest CAGR of 8.1% between 2026-2035.

• By end-user, the highest proportion, a little over 61%, was recorded in diagnostic laboratories in 2025, which is a result of high sample throughput and growing outsourcing of diagnostic services.

• Growing adoption is also being observed even in hospitals and research institutes as a result of technology integration, especially the integration of automated and high-throughput sample preparation technologies.

Significant Growth Factors

As stated in the Sample Preparation System of IVD Market Trends, there is high growth potential of the product due to the following reasons:

• Increasing Demand for Molecular and PCR-Based Diagnostics: The increasing application of molecular diagnostics, particularly PCR and next-generation sequencing (NGS), is substantially enhancing the necessity of an efficient system of sample preparation. Proper nucleic acid purification and extraction are very important in reliable test results, such as in infectious disease detection and oncology. The worldwide trend of precision diagnostics and early detection of diseases keeps on increasing the pressure to use automated and standardized workflows of preparing samples. QIAGEN introduced a state-of-the-art automated sample preparation platform in March 2024, which is designed to provide higher efficiency in the nucleic acid extraction process to be used in both PCR and NGS applications, which is suitable in high-throughput laboratory settings.

• Increased Laboratory Automation and Systems with High throughput have been adopted: Clinical laboratories have been moving towards automation to gain efficiency in the workflow, reduce turnaround time, and have fewer cases of human error. Consistency and scalability in large diagnostic laboratories (thousands of samples per day) are made possible by automated sample preparation systems, which facilitate consistent results and scalability. This is a trend that is increasing as there is an increase in the load of diagnostic tests worldwide. Thermo Fisher Scientific is enlarging its automated sample preparation family with fresh high-throughput options to automate the entire laboratory process and enhance productivity in clinical diagnostics in January 2025.

• Growing Focus on Infectious Disease Surveillance and Pandemic Preparedness: The past experience of global health crises has enhanced the investments in diagnostic infrastructure, specifically sample preparation technologies that are vital in large scale testing. Rapid and scalable diagnostic solutions are one of the priorities of governments and healthcare systems to enhance timely response to epidemics of infectious diseases. To support the pandemic preparedness in its diagnostics portfolio, Roche launched an improved automated sample preparation system to conduct testing of large volumes of samples in September 2023.

• Improved decentralization of testing along with the establishment of point-of-care testing: The trend is moving towards decentralized diagnostics, such as point-of-care (POC) and near-patient testing, which necessitates sample preparation methods that are small in size and easy to use. The systems are aimed at providing quicker outcomes in an environment other than the conventional laboratory, enhancing access and patient outcomes, particularly in remote and underserved areas. In June 2024, Danaher Corporation has been able to introduce improvements in portable diagnostic solutions, such as in-built sample preparation technologies, to enable a rapid test in decentralized healthcare facilities.

What are the Major Advances Changing the Sample Preparation System for IVD Market Today?

• Shift Toward Fully Automated Sample Preparation Workflows: IVD technique of sample preparation is changing the world; automation heightens the reliability of the sample preparation procedure, human error in sample preparation is lessened, and turnaround time in the diagnostic laboratories is decreased by a very high percentage. Automated platforms of nucleic acid extraction, purification, and manipulation have become the most important in high-throughput testing platforms of thousands of samples per day. The change is significantly dramatic in the field of molecular diagnostics, where the consistency of the results directly affects the outcome of the tests as well as medical outcomes. QIAGEN introduced the new sample preparation system automation in April 2024 and says that it simplifies end-to-end workflows both when working with PCR and with sequencing workflows.

• Microfluidic Technologies and Magnetic Bead Technologies: The efficiency and scalability of sample preparation are increasing with the innovations of magnetic bead-based sample preparation and of microfluidic sample handling. With these technologies, one can do the precise isolation of the DNA, RNA and proteins that are more yielding and purer and apply them to the more advanced diagnostic uses. Microfluidics is also miniaturizable, thereby lowering the volume of reagents to be used and increasing processing time in the small systems. In June 2024 Thermo Fisher Scientific declared new bead-based extraction kits, which are magnetic and improved the recovery of nucleic acids and optimized the findings using high-throughput diagnostic procedures.

• This issue has necessitated the need to test infections at a large scale: The growing amount of diagnostic testing, particularly of infectious diseases is exerting a strain on the need to have greater scale systems of sample preparation that can effectively process and work out the large volumes of samples. The laboratories also consider the solutions that would process hundreds and thousands of them in a day without being inaccurate especially in the outbreaks and regular screening programs. bioMerieux, in February 2025, claimed that it has expanded its molecular diagnostics offerings and has been aided by the growth in the use of high-throughput sample preparation answers in tests of infectious diseases.

Category Wise Insights

By Product Type

The Reasons Why Automated Sample Preparation Systems are the Market Leaders?

The highest portion of the IVD market is the automated sample preparation systems because they provide high-throughput, standardized, and error-free processing of clinical samples. These systems greatly decrease manual intervention and enhance reproducibility as well as the turnaround times, which are essential in large diagnostic labs that receive thousands of samples each day. As the need to perform PCR and other diagnostics requiring sequencing continues to rise, automation guarantees uniformity of workflow scalability. The trend of the full integration of sample-to-result systems is also contributing to the use of automated systems across the world. QIAGEN introduced a new state-of-the-art automated sample preparation system in March 2024 to streamline workflows based on high-throughput PCR and NGS in clinical labs.

Increasing Importance of Manual Sample Preparation Kits.

Sample preparation kits using manuals are still significant, especially in small labs, research, and low-resource settings. These kits are flexible, affordable, and easy to use without having to pay substantial capital investments. They are most commonly employed in extracting basic nucleic acid and handling samples in which the volumes of testing are intermediate. Although automation has been adopted, manual kits are not becoming redundant because they are affordable, and they can be used in various laboratory configurations. Bio-Rad Laboratories built on its line of manual sample preparation kits in July 2023 to serve smaller labs and academic research.

How is it that Reagents and Consumables are the Fastest-Growing Segment?

Reagents and consumables are a booming market since they are used consistently in each diagnostic test process. These products can include reagents used in nucleic acid extraction, purification buffers, and cartridges, among others, which are needed to guarantee accuracy and reproducibility. As the amount of diagnostic testing in the world is on the increase, particularly in the fields of infectious diseases and oncology, high-quality consumables are getting more and more demanded. This market segment has the advantage of having repeated purchases and, therefore, is a major source of income in the market. In February 2025, Merck KGaA said it was experiencing increased demand in its life science consumables due to the increase in diagnostic and research activity across the globe.

By Application

How Molecular Diagnostics is a Leader of the Market?

Molecular diagnostics has dominated the application segment since it is crucial in the detection of genetic materials related to diseases like cancer and infectious diseases, as well as genetic disorders. Sample preparation is also an important area of quality DNA/RNA extraction to be used in precise test results. There is an increasing push towards the use of PCR, real-time PCR and next-generation sequencing technologies, which are compelling the use of more complex preparation systems capable of managing complex workflows effectively. In January 2025, Thermo Fisher Scientific launched the new molecular workflow solutions with a sample preparation technology to enhance the efficiency of the genomic and clinical testing.

Increasing Significance of Infectious Disease Testing.

The rapid growth of infectious disease testing is observed because of the growing interest of the global attention to disease surveillance, early detection, and preparedness against the outbreaks. Samples should be well prepared in order to deal with high volumes of testing and reliable results in time-sensitive cases. Demand in this segment is also increasing faster due to the augmentation of diagnostic capabilities in the emerging markets. Roche enhances its infectious disease diagnostics portfolio with better sample preparation solutions in high-throughput testing settings in September 2023.

By End-User

Why Diagnostic Laboratories Control the Market?

The highest share in the Sample Preparation System of IVD is occupied by diagnostic laboratories due to the high level of sample processing and the necessity to use efficient and automated workflows. These laboratories are involved in regular and specialized tests and thus need scalable systems that are accurate and quick. The trend of outsourcing diagnostic services to specialized laboratories is also discovering a growth that is enhancing the power of this segment. Eurofins scientific news In April 2024, Eurofins Scientific increased the size of its diagnostic laboratory in order to handle increasing levels of test demand by adopting more automated sample preparation systems.

• Increasing Hospitals Adoption: The sample preparation systems are becoming an integrated diagnostic solution being adopted by hospitals, especially in critical care and rapid tests. The demand to diagnose in a timely and correct manner in the hospital setting is fueling the use of automated and compact systems that are capable of providing speedy results. The workflow efficiency is also being increased by integration with hospital information systems. In June 2024, Danaher Corporation developed its hospital-based diagnostic technologies, such as integrated sample preparation technologies to make clinical decisions quicker.

• Increasing the Role of research institutes: The institute of research is also one of the major users of the modern sample preparation methods in genomics, proteomics, and biomarker discovery. The systems that are used in these institutions need a high degree of precision and flexibility to facilitate the relatively complicated experimental processes. This segment is experiencing the demands to get innovative sample preparation solutions due to the increasing investments in life sciences research and individualized medicine. In August 2023, Agilent Technologies announced new sample preparation solutions to sustain advanced research technologies in genomics and life sciences.

Report Scope

Regional Analysis

How large is the Asia Pacific Market?

It is expected that the Asia Pacific Sample Preparation System IVD market will have a market size of USD 2.86 billion in 2025 and an estimated market size of USD 6.59 billion in 2035 with a CAGR of 8.7% over 2026-2035.

How come that in 2025 Asia Pacific Dominated the Market?

Asia Pacific was the leading market because of the blistering development of diagnostic facilities, growing evidence of the need to use molecular tests, and the high government concern about modernizing healthcare. The region has a substantial amount of the combined volumes of diagnostic testing globally as the population of some countries such as China and India is high. The increasing rates of infectious diseases and cancer have hastened the demand for effective sample processing systems. Moreover, market growth is being reinforced by greater investment in laboratory automation and growth of chain privatized diagnostics. Roche increased its capabilities in diagnostics manufacturing and supply within the Asian Pacific in May 2024 to fulfill the increasing demand for sample preparation and molecular testing solutions.

China Market Trends

China is one of the major growth drivers because of its fast developing diagnostics market as well as a high incentive towards local production of IVD technologies. Millions of diagnostic tests are performed in the country on a daily basis, and there is the demand of high-throughput and automated sample preparation systems. The use is being rapidly adopted with government efforts to enhance the power of laboratories and lessen dependence on imports. Advanced technology of preparation is also increasing in demand due to the growth in genomics research and precision medicine. In August 2023, BGI Genomics upgraded its lab with new automated sample preparation systems to take place in large-scale sequencing and diagnostic activities.

What is the Reason behind the steady North American Growth?

Smooth development of the healthcare ecosystem, a high level of automation, and the presence of one of the strongest diagnostics companies contribute to the steady growth of North America. Molecular and genetic testing is performed in the region at a high volume and needs a scalable and efficient solution to sample preparation. Precision medicine and control of infectious diseases are further encouraged by regulatory support and funding. Labs are moving towards complete automation of work flows to enhance efficiency and decrease turnaround time. Thermo Fisher Scientific announced in January 2025 that they had increased their manufacturing production of sample preparation technologies in the United States to keep up with increasing demand for molecular diagnostics.

How big is the U.S. Market?

The U.S. market is motivated by robust use of advanced molecular diagnostics, growing usage of automation in laboratories, and growing need for precision medicine. The large volume of testing in fields like oncology, infectious diseases, and genetic screening presupposes the high efficiency of the sample preparation systems. Workflow efficiency and accuracy are also being increased by adding AI and digital lab solutions. The availability of large market players and persistent innovation promotes growth. Danaher Corporation reinforced its diagnostics business in the U.S. in April 2024 through the development of the integrated sample preparation and molecular testing platforms.

Why Europe Is Obsessed with Efficiency and Standardization?

Europe is a well-established market that is fueled by good regulatory frameworks, a focus on quality standards, and extensive use of automated laboratory systems. In the region, accuracy, reproducibility, and compliance in diagnostic processes are prioritized, and hence advanced sample preparation systems are needed. Growth is also being supported by increasing demand for cancer diagnostics and tests for infectious disease. Modern laboratory infrastructure is being invested in by the public healthcare systems to enhance efficiency and patient outcomes. In February 2024, QIAGEN launched an additional sample preparation solutions enhancement for the European clinical labs in the name of standardizing the molecular test procedures.

Germany Market Trends

Germany is also one of the leading markets in Europe since it has a developed healthcare system and a high rate of laboratory automation. Molecular diagnostics and precision medicine are highly adopted in the country, and this supports the need to have reliable technologies in sample preparation. The development of digital health and the innovation of the life sciences, supported by the government, are another contributor to market growth. Technological innovations are also increasing at a faster rate due to collaboration between the industry players and research institutes. In June 2023, Merck KGaA increased its production capacities in the field of life science in Germany, including sample preparation and laboratory operation products.

Why Growing Middle East & Africa Region?

The Middle East & Africa region has become a prospective market with the rising investments in the healthcare infrastructure and the rise in the need for diagnostic services. Gulf countries are concerned with the development of laboratory strengths and the implementation of cutting-edge diagnostics. In Africa, gradual adaptation to sample preparation systems is being achieved through the enhancement of access to healthcare and increased awareness about diagnostics of diseases. Market development is also being assisted by international cooperations and funding projects. Abbott Laboratories increased its diagnostics in the Middle East and Africa in September 2024, to enhance accessibility to complex testing solutions, such as sample preparation technologies.

Top Players in the Market and Their Offerings

• Thermo Fisher Scientific

• QIAGEN

• Roche

• Agilent Technologies

• Danaher Corporation

• Bio-Rad Laboratories

• PerkinElmer

• Illumina

• Merck KGaA

• Becton Dickinson and Company

• Tecan Group

• Sartorius

• Others

Key Developments

The market is radically transforming as the main participants aim at advancing the processes of automation, the further development of the product portfolios, and the improvement of technological potentials of the sample preparation operations.

• In May 2024, Roche launched a new high-performance automated sample preparation system that has been combined with its molecular diagnostics solutions to enhance workflow and help reduce turnaround time in the high-throughput labs. This introduction enhanced the role of Roche in the integrated sample-to-result diagnostics systems in the world.

• Agilent Technologies has extended its sample preparation offerings in August 2023 with new offerings aimed at genomics and clinical research uses and at augmenting the accuracy and reproducibility of complicated laboratory processes.

These strategic advancements are empowering firms to be stronger in the market, increase their technological capacities, and also exploit the increasing demand for efficient and reliable sample preparation systems within the global IVD market.

The Sample Preparation System for IVD Market is segmented as follows:

By Product Type

• Automated Sample Preparation Systems

• Manual Sample Preparation Kits

• Reagents and Consumables

By Application

• Clinical Diagnostics

• Molecular Diagnostics

• Infectious Disease Testing

• Oncology Testing

• Others

By End-User

• Hospitals

• Diagnostic Laboratories

• Research Institutes

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America